6 best EDC platforms for UK CROs and sponsors in 2026

A protocol amendment lands on a Friday, and you know the drill: raise a change request with your electronic data capture (EDC) vendor, queue behind other client requests, then wait weeks before the update goes live across your UK and EU sites. Viedoc's EDC software turns that into a same-week task, with study builds typically live in as little as 8 weeks and mid-study changes handled by your own data managers rather than a vendor programmer. This comparison reviews six EDC platforms available to contract research organizations (CROs) and growth-stage sponsors running trials across the UK, evaluated on build speed, compliance credentials, no-code configuration, and total cost of ownership.

You're likely running several concurrent studies across the UK and mainland Europe, where UK GDPR and the EU's Annex 11 guidance can both apply depending on where your sites and processors sit. Every slow amendment cycle pushes back first-patient-in dates your sponsors are watching closely, and every added platform in your stack adds a validation burden your QA team has to carry.

Enterprise platforms built for global Phase III programs carry configuration cycles and vendor-side programming that a UK CRO running several Phase I and II studies at once can't easily absorb. Budget tools built for academic research rarely carry the audit trail depth a sponsor's QA director will ask for at RFP stage. The platforms below are judged on what matters here: build speed, how much you can do yourselves, and whether the paperwork holds up under inspection.

Best EDC solutions: quick comparison

These six EDC platforms represent the most evaluated options for UK CROs and growth-stage sponsors, reviewed across build speed, compliance credentials, and total cost of ownership.

1. Viedoc

Viedoc's EDC software is built for the multi-study, multi-country portfolio a UK CRO or growth-stage sponsor runs, with study builds typically live in as little as 8 weeks. The platform has powered more than 7,500 clinical studies across 75-plus countries, with a strong base of European site activity. A no-code Designer lets your data managers configure electronic case report forms (eCRFs) and edit checks directly, without waiting on a vendor programmer.

For teams managing UK and EU sites side by side, the paperwork behind that speed matters just as much: Viedoc's compliance posture covers GDPR, EU Annex 11, and ICH-GCP without a separate validation exercise per country. Unlimited user seats and transparent, study-based licensing mean growing your site count doesn't trigger a fresh per-user cost conversation with finance. For CROs building repeat volume with sponsors, Viedoc also runs a tiered CRO partner program.

Viedoc is ISO 27001 and SOC 2 Type II certified, hosted on Microsoft Azure with 99.99% uptime, and compliant with FDA 21 CFR Part 11, EU Annex 11, GDPR, and ICH-GCP. The platform runs in 40-plus languages, which matters once a study extends into mainland Europe. Support is available 24/7 with direct escalation paths rather than a ticket queue.

One Sr. Clinical Program Manager summed up the experience directly. "My experience with Viedoc has been excellent. The database is very customizable and has been able to meet the needs of each of our studies." – Amanda M., Sr. Clinical Program Manager

Verified proof points:

• Study scale: 7,500+ global studies across 75+ countries
• Build speed: Study builds typically completed in as little as 8 weeks
• Compliance: FDA 21 CFR Part 11, EU Annex 11, GDPR, ICH-GCP; ISO 27001 and SOC 2 Type II certified
• Uptime and hosting: 99.99% uptime, hosted on Microsoft Azure
• Pricing: Unlimited user seats, transparent study-based licensing, no per-user fees
• Support: 24/7 customer success support with direct escalation paths

2. Medidata

Medidata offers Rave EDC, an electronic data capture system built to capture, manage, clean, and report site, patient, and lab-reported data across Phase I to IV trials. Rave EDC sits at the center of the Medidata Clinical Cloud, connecting to Medidata's own eConsent, eCOA, RTSM, and imaging applications so data flows between them without a separate reconciliation step. The platform offers a drag-and-drop study designer, though builds for complex protocols in large pharma programs typically involve Medidata's own professional services team alongside self-service configuration. Rave EDC is most established in large pharma and big CRO settings running high-volume, multi-thousand-site programs, and its long operating history means it is a familiar system to site staff who have worked on major sponsor trials before.

3. Veeva Vault EDC

Veeva offers Veeva EDC, a cloud-based system for capturing and reviewing clinical trial data as part of the wider Veeva Clinical Platform. The platform provides a point-and-click study builder, a rules engine for edit checks, and zero-downtime handling of protocol amendments, where updated fields are flagged for site staff without a full database migration. Veeva EDC connects to Veeva's own Clinical Database, RTSM, CTMS, and eTMF applications, and it supports DICOM imaging review directly within the EDC. For a CRO or sponsor already running other parts of the Veeva Vault suite, this connected architecture reduces the number of separate vendor integrations to manage, though adopting Veeva EDC as a standalone system means taking on the wider Vault ecosystem's implementation requirements.

4. Castor EDC

Castor EDC is a cloud-native, no-code electronic data capture platform used across more than 170 countries, with a low-code eCRF builder that lets teams design and edit forms without a programmer. The platform supports online and offline data capture, real-time edit checks, and CDASH-compliant form templates, and it is FDA 21 CFR Part 11, GDPR, and ISO 27001 compliant. Castor's eCOA and eConsent modules run on the same underlying platform as its EDC, so participant-reported data and site data share one database rather than requiring a separate sync. Castor's own product listing covers EDC, eCOA, eConsent, and AI-assisted chart review, without a dedicated randomization and trial supply management module, so sponsors needing RTSM alongside EDC typically pair it with a separate system.

5. Medrio

Medrio provides a fully validated, audit-ready EDC platform backed by more than 20 years of clinical use across thousands of completed clinical trials. The suite pairs EDC and CDMS with ePRO, eConsent, and RTSM modules, positioned for sponsors and CROs who want to configure and adapt studies without a programmer. Medrio also describes a dedicated services team on its site, supporting everything from database build and data management to biostatistical analysis and regulatory-ready outputs. This combination of self-service configuration with available expert support is aimed at teams who want programmer independence day to day, with services on hand for more complex builds. Medrio's own site emphasizes early-phase and device-focused study support alongside its broader pharma and biotech client base.

6. Oracle Health

Oracle offers Clinical One Data Collection, an electronic data capture system that gathers datasets from multiple sources, including forms, wearables, and electronic health records (EHR), into a single platform. The system supports building a study in weeks rather than months, with mid-study changes deployed without a lengthy migration process, according to Oracle's own product page. Clinical One also integrates with Oracle's own safety solutions for adverse event reporting, using the ICH E2B(R3) standard to route serious adverse events between site and sponsor systems. Clinical One runs on Oracle Cloud Infrastructure and is positioned by Oracle for sponsors and CROs running studies across all trial phases, with EHR interoperability as a distinguishing focus area on its current product page.

What to look for in EDC solutions for UK CROs and sponsors

Study build and amendment velocity

How long it takes to go from signed protocol to first-patient-in, and how quickly an amendment goes live once a protocol changes, sets the pace for your entire study timeline. A slow amendment cycle on one study creates a scheduling bottleneck across a whole portfolio.

Best-in-class platforms complete a standard build in weeks rather than months, and handle amendments through configuration changes rather than a full database migration. Ask any shortlisted vendor for their typical build timeline and their process for mid-study changes, not just their marketing claim.

No-code versus programmer-dependent configuration

Whether your own data managers can build and amend a study themselves, or whether every change routes through a vendor's programming team, determines how much of your delivery timeline you actually control.

Best-in-class platforms offer drag-and-drop study design with certified training measured in days rather than weeks. Viedoc's no-code Designer is one example, with certified training typically completed in a couple of days. Programmer-dependent platforms create a queue every time you need a change, and that queue is invisible until you're already inside it.

UK and EU regulatory coverage

A platform used across UK and European sites needs to support current UK GDPR requirements and, where applicable, the EU's Annex 11 guidance on computerized systems, without a separate validation exercise for each region. ICH-GCP compliance is the baseline; the harder question is how the audit trail holds up when a regulator or sponsor QA team reviews it.

Best-in-class platforms carry FDA 21 CFR Part 11, EU Annex 11, and GDPR compliance as standard, with structured, exportable audit trails rather than logs that need reformatting before an inspection.

Audit trail depth and inspection-readiness documentation

QA and CSV teams need more than a compliance checkbox; they need validation documentation they can hand to an inspector without weeks of preparation. Best-in-class vendors provide a structured, ready-made inspection-readiness pack, like Viedoc's Inspection Readiness Packet, rather than leaving QA to assemble documentation from scratch. Without this, every audit becomes a fire drill instead of a formality.

Support availability and escalation pathways

Multi-country trials run across time zones, and a platform issue at 2am UK time still needs a real response, not a ticket that waits for Monday. Best-in-class support is available 24/7 with a named escalation path, not a ticket queue with no defined response window.

How to choose the right EDC solution for UK CROs and sponsors

Step 1: Assess your build and amendment volume

How many studies are you running concurrently across the UK and Europe, and how often do protocols change mid-study? A platform that handles one study well but buckles under three concurrent amendments will show its limits when you can least afford it.

Step 2: Evaluate who actually builds and maintains your studies

Decide whether your own data managers should configure and amend studies, or whether you're comfortable routing every change through a vendor's programming team. This choice affects your delivery timeline more than almost any other platform feature.

Step 3: Map your compliance footprint across UK and EU sites

Confirm which regulatory frameworks apply to your trial footprint, UK GDPR, EU Annex 11, ICH-GCP, and, for any US-facing data, HIPAA, before you shortlist. A platform compliant everywhere you operate today but not where you plan to expand creates a problem you'll have to solve twice.

Step 4: Scrutinize the support model at the moments that matter most

Ask what happens at 2am during database lock week, not what the standard support hours are on the sales call. A 24/7 SLA with a named escalation path is a different product to a ticket queue with no defined response time.

Step 5: Choose a platform sized for your portfolio, not a legacy enterprise stack

UK CROs and growth-stage sponsors need a platform that combines audit-ready compliance with deployment speed and cost transparency that large enterprise systems, built for global Phase III programs, rarely offer at this scale. Viedoc's EDC software is built for this segment, with no-code study builds typically live in as little as 8 weeks, transparent study-based pricing, and 24/7 customer success support across 7,500-plus completed studies. If that matches how you operate, you can book a demo or request a proposal to see it against your own portfolio.

Frequently asked questions

What is the best EDC solution for UK CROs and growth-stage sponsors?

Viedoc's EDC software is the strongest fit for UK CROs and growth-stage sponsors running multiple concurrent Phase I and II studies, combining study builds typically live in as little as 8 weeks with GDPR, EU Annex 11, and ICH-GCP compliance built in from the start. Its no-code Designer lets your own data managers configure and amend studies without a vendor programmer, a direct margin advantage when you're running several trials at once. Medidata is the category benchmark for large-scale Phase III pharma programs but is generally sized, and priced, for that scale rather than a UK SMID CRO's portfolio. Castor EDC is a credible no-code alternative for teams that don't need a bundled randomization module.

What should I look for when choosing an EDC platform for UK and European trials?

Prioritize study build and amendment speed, since a platform that requires vendor programming for every protocol change will slow every study in your portfolio, not just one. Confirm compliance coverage for UK GDPR, EU Annex 11, and ICH-GCP specifically, rather than a generic compliance claim, and ask to see the audit trail and validation documentation directly. Check the support model too, since 24/7 availability with a named escalation path is a different proposition to standard business-hours ticketing.

How long does it take to build and deploy a clinical study on a modern EDC platform?

Timelines vary by vendor and study complexity, but modern no-code platforms typically complete a standard study build in weeks rather than months, with mid-study amendments handled through configuration changes rather than a full database migration. Viedoc, for example, reports study builds typically live in as little as 8 weeks. Platforms that still route builds and amendments through a dedicated programming team tend to run closer to three months for a comparable study.

What compliance certifications should I look for in an EDC platform used across UK and EU sites?

Look for FDA 21 CFR Part 11 compliant electronic signatures, EU Annex 11 coverage for computerized systems, GDPR compliance for personal data handling, and ICH-GCP alignment as a baseline. ISO 27001 and SOC 2 Type II certifications indicate independently audited security and operational controls, which QA and CSV teams will ask about directly. Ask whether inspection-readiness documentation is included as standard or requires a separate service engagement.

What is the difference between programmer-dependent and no-code EDC configuration?

Programmer-dependent platforms route every study build and amendment through a vendor's technical team, which adds cost and creates a scheduling dependency outside your control. No-code platforms use drag-and-drop or point-and-click tools that let your own data managers build and amend studies directly, typically after a short certified training period. The practical difference shows up at amendment time: a no-code platform can push a protocol change live in days, while a programmer-dependent one may take weeks to queue and complete the same change.

What is a Viedoc Inspection Readiness Packet (VIRP)?

The Viedoc Inspection Readiness Packet (VIRP) is a structured set of validation and compliance documentation designed to help clinical trial teams prepare for regulatory audits and inspections. It's built to align with expectations from major regulatory bodies, including guidance on computerized systems and electronic records in clinical trials. VIRP is included for Viedoc customers at no additional cost, reducing the amount of documentation a QA team needs to assemble from scratch ahead of an inspection.

Making the right EDC choice for UK CROs and sponsors

The EDC platforms reviewed here span from large enterprise systems built for global Phase III programs to leaner, no-code tools sized for smaller portfolios, with most now converging on some form of drag-and-drop study design regardless of scale. The global eClinical software market was estimated at around $11 billion in 2025 and is projected to keep growing at close to 14% annually.

Match platform to requirement using a few core variables: how many studies you run concurrently, how complex your protocols are, which regulatory frameworks apply, and how your budget model is structured. UK and European buyers generally weight compliance depth and vendor stability more heavily than speed alone, while sponsors moving from Phase I into Phase II should expect validation expectations to rise quickly.

Switching EDC platforms mid-portfolio carries a real validation and retraining cost, which is why getting this choice right at the outset matters more than any single feature comparison.

Why Viedoc is the best EDC choice for UK CROs and sponsors

If you're running multiple concurrent studies across UK and European sites, Viedoc's EDC software is built around the problem that shapes most of your delivery risk: how fast you can build and amend a study without waiting on someone else's schedule. Study builds are typically live in as little as 8 weeks, and the no-code Designer means your data managers make protocol changes directly, without routing every amendment through a vendor programming queue.

Beyond speed, Viedoc gives you unlimited user seats and transparent, study-based pricing, so growing your portfolio doesn't trigger a fresh licensing conversation every time you add a site. The Viedoc Inspection Readiness Packet gives your QA team a documented head start on inspection readiness, and 24/7 support means a platform issue doesn't wait for UK business hours to get resolved.

Viedoc is ISO 27001 and SOC 2 Type II certified, compliant with FDA 21 CFR Part 11, EU Annex 11, GDPR, and ICH-GCP, with a track record spanning more than 7,500 completed studies since the company was founded in 2003.

If you want a platform your data team can build and amend independently, without enterprise overhead or unpredictable per-study costs, Viedoc is designed for exactly that. Book a demo or request a proposal and we'll walk you through build speed, compliance, and module depth against your own UK and European portfolio.